Mosquito-borne diseases have been posing major health risks across the world. Mosquito-borne diseases are spread to people through the bites of infected mosquitoes. Diseases such as Zika virus disease, dengue, chikungunya, and yellow fever are caused by mosquito-borne viruses. The mosquito borne disease market consists of devices and equipment used in the diagnosis and treatment of mosquito-borne diseases. Advancements in diagnosis technologies have enabled timely detection and treatment of mosquito-borne diseases. 

The global mosquito borne disease market is estimated to be valued at US$ 3.59 Bn in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 to 2031. 

Rising incidences of vector-borne diseases like malaria, dengue, chikungunya and yellow fever are expected to drive the demand for effective diagnostic and treatment methods in the market. Various government initiatives to curb the spread of mosquito-borne diseases are further expected to support market growth.

Key Takeaways 

Key players operating in the mosquito borne disease market are Masimo, Medtronic Plc, Nihon-Kohden Corporation, GE Healthcare, Koninklijke Philips N.V., Hill-Rom Services, Inc., Smiths Medical, Nonin, MICROTEK, OSI Systems, Inc. Honeywell International Inc., Promed Technology Co.Ltd., Beurer, Contec Medical Systems Co., Ltd., ChoiceMMed, CONMED Corporation, Stryker, Medline Industries, Inc., Curbell Medical Products, Inc., and Ecomed. 

The Mosquito Borne Disease Market Demand provides opportunities for companies to launch innovative diagnosis solutions such as affordable point-of-care testing kits. Growing awareness about vector-borne illnesses and availability of government funding for mosquito-control activities are further expected to drive growth.

The market is witnessing increasing focus on expanding access to diagnostics, immunization and treatment in emerging and underdeveloped regions heavily impacted by mosquito-borne diseases like Latin America, Asia Pacific and Africa.

Market Drivers

The rising incidences of dengue, chikungunya, and malaria globally are expected to be a major factor driving the growth of the mosquito borne disease diagnostic market. According to the World Health Organization (WHO), there were around 216 million cases of malaria reported globally in 2020. The favorable weather conditions and rising temperature are facilitating the growth of mosquito population contributing to the increased transmission of dengue and malaria. For instance, areas with warmer climate have witnessed higher instances of mosquito breeding and diseases transmission. Thus, the changing climatic conditions are supporting the growth of mosquitoes and driving the need for advanced diagnostic and treatment of mosquito borne diseases.

Get More Insights on- Mosquito Borne Disease Market

For Deeper Insights, Find the Report in the Language that You want: